AU4662400A - Role of vascular endothelial growth factor-b (vegf-b) in developing bones and uses thereof - Google Patents

Role of vascular endothelial growth factor-b (vegf-b) in developing bones and uses thereof

Info

Publication number
AU4662400A
AU4662400A AU46624/00A AU4662400A AU4662400A AU 4662400 A AU4662400 A AU 4662400A AU 46624/00 A AU46624/00 A AU 46624/00A AU 4662400 A AU4662400 A AU 4662400A AU 4662400 A AU4662400 A AU 4662400A
Authority
AU
Australia
Prior art keywords
vegf
role
growth factor
vascular endothelial
endothelial growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU46624/00A
Inventor
Karin Aase
Kari Alitalo
Ulf Eriksson
Arja Kaipainen
Birgitta Olofsson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ludwig Institute for Cancer Research Ltd
Helsinki University Licensing Ltd
Original Assignee
Ludwig Institute for Cancer Research Ltd
Helsinki University Licensing Ltd
Ludwig Institute for Cancer Research New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ludwig Institute for Cancer Research Ltd, Helsinki University Licensing Ltd, Ludwig Institute for Cancer Research New York filed Critical Ludwig Institute for Cancer Research Ltd
Publication of AU4662400A publication Critical patent/AU4662400A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A61K38/1866—Vascular endothelial growth factor [VEGF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
AU46624/00A 1999-04-26 2000-04-26 Role of vascular endothelial growth factor-b (vegf-b) in developing bones and uses thereof Abandoned AU4662400A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13093599P 1999-04-26 1999-04-26
US60130935 1999-04-26
PCT/US2000/011096 WO2000064261A1 (en) 1999-04-26 2000-04-26 Role of vascular endothelial growth factor-b (vegf-b) in developing bones and uses thereof

Publications (1)

Publication Number Publication Date
AU4662400A true AU4662400A (en) 2000-11-10

Family

ID=22447069

Family Applications (1)

Application Number Title Priority Date Filing Date
AU46624/00A Abandoned AU4662400A (en) 1999-04-26 2000-04-26 Role of vascular endothelial growth factor-b (vegf-b) in developing bones and uses thereof

Country Status (2)

Country Link
AU (1) AU4662400A (en)
WO (1) WO2000064261A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ529915A (en) * 2001-06-20 2007-07-27 Ludwig Inst Cancer Res Stimulation of vascularization of ischemic tissue by angiogenesis with VEGF-B186
WO2004022095A1 (en) * 2002-09-04 2004-03-18 Abtech Anti-idiotypic antibodies as vegf or fgf agonists for bone therapy
PL1781321T3 (en) 2004-08-02 2014-07-31 Zenyth Operations Pty Ltd A method of treating cancer comprising a vegf-b antagonist

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5194596A (en) * 1989-07-27 1993-03-16 California Biotechnology Inc. Production of vascular endothelial cell growth factor
US5607918A (en) * 1995-03-01 1997-03-04 Ludwig Institute For Cancer Research Vascular endothelial growth factor-B and DNA coding therefor
US5928939A (en) * 1995-03-01 1999-07-27 Ludwig Institute For Cancer Research Vascular endothelial growth factor-b and dna coding therefor

Also Published As

Publication number Publication date
WO2000064261A9 (en) 2002-04-04
WO2000064261A1 (en) 2000-11-02

Similar Documents

Publication Publication Date Title
AU2001233526A1 (en) Stent delivery system and method of use
AU2001281344A1 (en) Angulated stent delivery system and method of use
AU2002230831A1 (en) Compositions of human proteins and method of use thereof
AU5141500A (en) Self-expanding stent delivery system and method of use
AU5781100A (en) Methods and kits for the inhibition of hyperplasia in vascular fistulas and grafts
AU2001277719A1 (en) Stent for blood vessel and material for stent for blood vessel
AU2001285059A1 (en) Coated vascular grafts and methods of use
AU2001275253A1 (en) Orthopedic implant and method of making metal articles
AU4871099A (en) Stent delivery device and method of use
AU4904601A (en) Stent and stent delivery assembly and method of use
AU2001241909A1 (en) Large vessel stents and occluders
HK1050032A1 (en) Sputtering targets and method of making same
AU2777399A (en) Bone prosthesis and method of implantation
AU2001288638A1 (en) Systems and methods of use for delivering beneficial agents for revascularizing stenotic bypass grafts and other occluded blood vessels and for other purposes
AU2733697A (en) Antisense inhibitors of vascular endothelial growth factor (vegf/vpf) expression
AU7714898A (en) Bone morphogenetic proteins and their use in bone growth
EP1581147A3 (en) Vascular prosthesis and methods of use
AU4520801A (en) Novel substituted phenanthridinones and methods of use thereof
AU1813101A (en) Bifurcated stent and method of making
AU2001255767A1 (en) Methods and reagents for tissue engineering of cartilage in vitro
AU3146800A (en) Determination of sperm concentration and viability for artificial insemination
ZA99476B (en) Novel sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion.
AUPQ196799A0 (en) Method of preservation of amnion and uses thereof
HUP0200827A2 (en) Vascular endothelial cell growth factor variants and uses thereof
AU2001249074A1 (en) Human hepatocyte growth factor activator inhibitor homologue

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase